KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Apr 10, 2026 >>  ABB India 6865.95  [ 3.82% ]  ACC 1424.5  [ 2.30% ]  Ambuja Cements 445.05  [ 2.52% ]  Asian Paints 2359.4  [ 3.97% ]  Axis Bank 1351.45  [ 2.49% ]  Bajaj Auto 9813.65  [ 3.14% ]  Bank of Baroda 276  [ 0.73% ]  Bharti Airtel 1870  [ 0.60% ]  Bharat Heavy 284.65  [ 2.72% ]  Bharat Petroleum 299.35  [ 0.66% ]  Britannia Industries 5558.95  [ 1.55% ]  Cipla 1229.6  [ 0.44% ]  Coal India 434.25  [ -4.39% ]  Colgate Palm 1939.5  [ 1.65% ]  Dabur India 436.4  [ 1.63% ]  DLF 569.6  [ 1.27% ]  Dr. Reddy's Lab. 1232  [ 1.62% ]  GAIL (India) 154.05  [ 1.25% ]  Grasim Industries 2745.8  [ 0.20% ]  HCL Technologies 1450.9  [ -0.98% ]  HDFC Bank 810.4  [ 1.65% ]  Hero MotoCorp 5468.45  [ 3.46% ]  Hindustan Unilever 2155.6  [ 1.03% ]  Hindalco Industries 992.25  [ 0.67% ]  ICICI Bank 1322  [ 3.22% ]  Indian Hotels Co. 641.3  [ 1.98% ]  IndusInd Bank 830.6  [ 1.93% ]  Infosys 1292.35  [ -2.94% ]  ITC 304.2  [ 0.40% ]  Jindal Steel 1217.55  [ 1.49% ]  Kotak Mahindra Bank 374.75  [ 0.75% ]  L&T 3959.9  [ 1.61% ]  Lupin 2332.7  [ 1.59% ]  Mahi. & Mahi 3261.8  [ 2.98% ]  Maruti Suzuki India 13710.95  [ 0.89% ]  MTNL 29.44  [ 5.26% ]  Nestle India 1249  [ 1.62% ]  NIIT 65.23  [ 1.91% ]  NMDC 85.08  [ 0.79% ]  NTPC 380.3  [ 0.49% ]  ONGC 286.55  [ -0.62% ]  Punj. NationlBak 111.7  [ 1.92% ]  Power Grid Corpn. 302.6  [ 1.49% ]  Reliance Industries 1350.15  [ 1.56% ]  SBI 1066.7  [ 2.48% ]  Vedanta 745.1  [ 1.07% ]  Shipping Corpn. 243.25  [ 1.82% ]  Sun Pharmaceutical 1654.7  [ -3.65% ]  Tata Chemicals 690.25  [ 6.29% ]  Tata Consumer 1093.5  [ 1.42% ]  Tata Motors Passenge 342.55  [ 2.81% ]  Tata Steel 206.6  [ 0.66% ]  Tata Power Co. 399.5  [ 1.25% ]  Tata Consult. Serv. 2524.35  [ -2.45% ]  Tech Mahindra 1440.4  [ -1.44% ]  UltraTech Cement 11589.9  [ 1.29% ]  United Spirits 1267.5  [ 1.39% ]  Wipro 204.85  [ 0.96% ]  Zee Entertainment 82.02  [ 3.47% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AKUMS DRUGS & PHARMACEUTICALS LTD.

10 April 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE09XN01023 BSE Code / NSE Code 544222 / AKUMS Book Value (Rs.) 204.41 Face Value 2.00
Bookclosure 52Week High 623 EPS 21.49 P/E 24.01
Market Cap. 8120.74 Cr. 52Week Low 409 P/BV / Div Yield (%) 2.52 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Our Company was incorporated as a public limited company under the Companies Act, 1956 as `Akums Drugs and Pharmaceuticals Limited', pursuant to a certificate of incorporation dated April 19, 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13, 2004.

Major Events and Milestones:
2004
-Incorporation of the Company
-Established first plant for oral dosage commissioned at 19, 20, 21, sector 6A, Haridwar, Uttarakhand

2007
-Established dedicated manufacturing site for oral liquid dosage at 22, Sector 6A, Sidcul, Haridwar, Uttarakhand and sterile products at 2,3,4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand

2009
-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals

2010
-Dedicated a facility for hormones at 48, Sector 6A, SIDCUL, Haridwar, Uttarakhand
-Dedicated a facility for cosmetics and dermatology at 47, Sector 6A, SIDCUL, Haridwar, Uttarakhand
-Incorporated Akumentis Healthcare Limited to venture into branded formulations

2011
-Innovated bi-layered sustained release tablets for the first time

2012
-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities

2013
-Innovated tablet-in-tablet sustained release tablets for the first time
-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities
-Expanded into the African market

2015
-Expanded into the Asian market
-Established research and development laboratory in Mumbai, Maharashtra to venture into regulated market

2016
-Maxcure Nutravedics Limited received US-NSF certification

2019
-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder

2021
-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs
-Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited

2022
-Plant at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and plant at 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand accredited European Union-Good Manufacturing Practices, qualifying for exports to European markets
-Acquisition of a facility in Haridwar, Uttarakhand by Akums Healthcare Limited and a facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited

2023
-Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited
-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

2024 -The Company has informed to exchange regarding new product launches.